SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MorphoSys AG (MOR)
An SI Board Since January 2000
Posts SubjectMarks Bans
421 15 0
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
171MorphoSys Q2 results: Tax items led to small net loss, but well on track to deliGermanecki-7/28/2006
170MorphoSys Reports Six Months 2006 Results - MorphoSys Raises Financial Guidance Germanecki-7/28/2006
169MorphoSys Raises Financial Guidance for 2006, revenues 52(50)EBit 6 (1)! PublisGermanecki-7/27/2006
168Invitation to Q2 2006 Conference Call of MorphoSys AG on July 28, 2006 PublisheGermanecki-7/24/2006
167Until 28.7. there will be a significant increase of the forcast! efkabe.de MorpGermanecki-7/23/2006
166SocGen/MorphoSys: Our DCF model yields a fair value of €66 on www.sgresearch.soGermanecki-7/8/2006
165WestLB Ups Morphosys Target On Novartis News Tuesday, June 27, 2006 5:57:19 AMGermanecki-6/27/2006
164MorphoSys CEO sees positive effect on earnings from Novartis collaboration 26.0Germanecki-6/26/2006
163MorphoSys AG (DE) - MorphoSys Announces Expansion of Collaboration with NovartisGermanecki-6/23/2006
162Morphosys in US-Dollar in the last 2 years efkabe.de And the nbi: bigcharts.mGermanecki-6/11/2006
161MorphoSys and OncoMed Pharmaceuticals Sign Agreement for Use of HuCAL GOLD®Germanecki-6/10/2006
160MorphoSys AG <b>Strong Speculative Buy Rating In Initiating Coverage</bGermanecki-5/24/2006
159WSJ(5/24) Morphosys Looks To Secure More Partnerships (From THE WALL STREET JOGermanecki-5/24/2006
158MorphoSys Says CAT Bid Means Fewer Rivals 23 May 2006 10:40 GMT =DJ INTERVIEW: Germanecki-5/23/2006
157MorphoSys and Schering-Plough Sign R&D Agreement Press Release Martinsried/Germanecki-5/17/2006
156MorphoSys’ Antibodies by Design Establishes Antibody Series in Partnership with Germanecki-5/15/2006
155OXFORD MAIL : Antibody firm boosts biotech community By Andrew Smith OxfordshirGermanecki-5/9/2006
154WestLB Ups MorphoSys Target To EUR59.50 Tuesday, May 02, 2006 9:00:36 AM ET DoGermanecki-5/2/2006
153WestLB Reviews Morphosys Target Post 1Q Friday, April 28, 2006 9:45:23 AM ET DGermanecki-4/28/2006
152First quater: net incom increased from 0,5 to 4,9mio€, revenues increased by 100Germanecki-4/28/2006
151Invitation to Q1 2006 Conference Call of MorphoSys AG on April 28, 2006 MARTINGermanecki-4/25/2006
150Strong start to FY 2006 estimated - Buy ahead of Q1 2006 results Preview of an Germanecki-4/24/2006
149Equinet: Morphosys Buy, share price target of EUR 60 After the recent share priGermanecki-4/22/2006
148MorphoSys Annual Report 2005 available on-line morphosys.comGermanecki-4/4/2006
147announced 1Q free cash flow of EUR10M is significantly higher than estimates MoGermanecki-3/29/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News